News

USA: A recent clinical trial has shown that Lorundrostat, a novel aldosterone synthase inhibitor, significantly lowers blood ...
A new study published in the journal of Cureus showed that more than one-third of people with diabetes have silent myocardial ...
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...
Ahmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food ...
The Directorate General of Foreign Trade (DGFT), under the Ministry of Commerce and Industry, has issued Public Notice No. 03 ...
According to a study published in the Annals of Family Medicinereports that using inhaled corticosteroids for more than 24 ...
At the recent SEC meeting for Ophthalmology held on 19th March 2025, the expert panel reviewed the proposal to conduct a ...
A new study led by researchers at Yale University suggests that early-life exposure to two widespread environmental ...
A new study published in the Journal of American Medical Association showed that Rilzabrutinib decreased itching and hives ...
New Delhi- In less than a week, the National Testing Agency (NTA) is going to conduct the National Eligibility and Entrance ...
Pakistan: A recent comparative study has shed light on the significant impact of obesity on joint replacement surgery ...
AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib), 15 mg, once daily, ...